Regeneron Pharma (REGN) PT Raised to $800 at Cantor Fitzgerald on Commercial Estimates
Tweet Send to a Friend
Cantor Fitzgerald analyst Carter Gould raised the price target on Regeneron Pharma ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
